Akari Therapeutics Discusses Breakthrough Potential of AKTX-101 and Novel Spliceosome-Modulating ADC Platform in Virtual Investor “What This Means” Segment Following ASCO Abstract Acceptance
Range Impact Announces West Virginia Attorney and Business Advisor Michael Simon Has Joined the Company as a Strategic Advisor
Creatd (CRTD) Announces OG Collection, Inc. Equity Realignment as Part of Broader Uplisting Strategy
TechResources.ai names Mike Farrell as President to scale expansion & growth
Kyivstar Group Appoints Taner Kızıltoprak as Chief Financial Officer, effective July 1, 2026
